期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

浅析肝纤维化的发生机制

暂未订购
导出
摘要 目的:肝纤维化是慢性肝损伤后出现的一个最普遍的病变,肝纤维化的持续发展最终将导致肝硬化及其并发症(如肝癌)的发生。本文从肝损伤如何导致炎症反应、促进肝脏中某些细胞群体的激活和增殖与重建细胞外基质等方面进行了探讨,旨在阐明肝纤维化的病变机制。
作者 王晓丽
机构地区 临汾职业技术学院
出处 《山西职工医学院学报》 CAS 2013年第1期45-48,共4页 Journal of Shanxi Medical College for Continuing Education
关键词 肝纤维化 炎症反应 成纤维细胞 肝星状细胞 枯否细胞
分类号 R575.2 [医药卫生—消化系统]
  • 相关文献

参考文献29

  • 1陆伦根,Catherine H Wu,George Y Wu.肝纤维化[J].胃肠病学,2000,5(2):80-82. 被引量：2
  • 2POVERO D, BUSLETYA C, NOVO E,et al. Liver Fibrosis: a Dy- namic and Potentially Reversible Process [ J ]. Histol Histopathol, 2010, 25(8) : 1075-91.
  • 3SHIM J Y, KIM M H, KIM H D, et al. Protective Action of the Im- munomodulator Ginsan against Carbon Tetrachloride-Induced liver In- jury via Control of Oxidative Stress and the Inflammatory Response [ J]. Toxicology and Applied Pharmacology, 2010, 242 ( 3 ) : 318- 325.
  • 4WASMUTH H E, TACKE F, TRAUTWEIN C. Chemokines in Liver Inflammation and Fibrosis F ,2010 [ C ]. Thieme Medical Publishers.
  • 5DANSETI'E P, BONIERBALE E, MINOLETYI C, et al. Drug-in- duced Immunotoxicity [ J ]. European Journal of Drug Metabolism and Pharmacokinetics, 1998, 23(4) : 443-445.
  • 6MANNS M P, VOGEL A. Autoimmune Hepatitis from Mechanisms to Therapy [J]. Hepatology, 2006, 43(1): 132-134.
  • 7RUSSO F P, ALISON M R, BIGGER B W, et al. The Bone Marrow Functionally Contributes to Liver Fibrosis [ J ]. Gastroenterology, 2006, 130(6): 18-21.
  • 8VIG P, RUSSO F P, EDWARDS R J,et al. The Sources of Paren- chymal Regeneration after Chronic Hepatocellular Liver Injury in Mice [J]. Hepatology, 2006, 43(2) : 316-318.
  • 9ZAJICEK G, OREN R, WEINREB JR M. The Streaming Liver [J]. Liver, 1985, 5(6) : 293-300.
  • 10FAUSTO N, CAMPBELL J S, RIEHLE K J. Liver Regeneration [J]. Hepatology, 2006, 43( 1 ) : 45-53.

二级参考文献37

  • 1Geerts A, Vrijsen R, Schelliack P, Wisse E. Retinol affects the phenotype andprotein synthesis of fat storing cell derived myofibroblasts in vitro. In:Wisse E, KnookDL, Decker K, eds. Cells of the hepatic sinusoids. Leiden, The Netherlands: The KupfferCell Foundation, 1989. vol 2: 20～24.
  • 2Mak KM, Leo MA, Lieber CS. Alcoholic liver injury in baboons: transformation oflipocytes to transitional cells. Gastroenterology, 1984, 87:188～200.
  • 3Friedman SL. Closing in on the signals of hepatic fibrosis. Gastroenterology, 1997,112: 1406～1409.
  • 4Pinzani M, Milani S, Grappone C, Weber FL Jr,Gentilini P, Abboud HE. Expression ofplateletderived growth factor in a model of acute liver injury. Hepatology, 1994, 19: 701～707.
  • 5Wong L, Yamasaki G, Johnson RJ, Friedman SL.Induction of beta-platelet-derivedgrowth factor receptor in rat hepatic lipocytes during cellular activation in vivo and inculture. J Clin Invest,1994, 94: 1563～1569.
  • 6Marra F, Gentilini A, Pinzani M, Choudhury GG,Parola M, Herbst H, Dianzani MU,Laffi G,Abboud HE, Gentilini P. Phosphatidylinositol 3-kinase is required forplatelet-derived growth factor's actions on hepatic stellate cells. Gastroenterology,1997, 112: 1297～1306.
  • 7Gressner AM, Bachem MG. Molecular mechanisms of liver fibrogenesis-a homage to therole of activated fat-storage cells. Digestion, 1995, 56:335～346.
  • 8Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha inchronic liver disease. Effects of interferon alpha therapy. N Engl J Med, 1991, 324: 933～940.
  • 9Roberts AB, Sporn MB, Assoian RK, Smith JM,Roche NS, Wakefield LM, Heine UI,Liotta LA,Falanga V, Kehrl JH, Fauci AS. Transforming growth factor type beta: rapidinduction of fibrosis and angiogenesis in vivo and stimulation of collagen formation invitro. Proc Natl Acad Sci U S A, 1986, 83: 4167～4171.
  • 10Milani S, Schuppan D, Herbst H, Surrenti C.Expression of transforming growthfactor beta, in normal and fibrotic human liver. In: Gressner A,Ramadori G, eds. Molecularand cell biology of liver fibrogenesis. Dordrecht, The Netherlands:Kluwer AcademicPublishers, 1992. 254～263.

共引文献1

山西职工医学院学报
2013年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部